Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial Other Scholarly Work

Diaz, John, Duan, Wenrui, Gatcliffe, Troy et al. (2021). Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial . GYNECOLOGIC ONCOLOGY, 162 S66-S67.

cited authors

  • Diaz, John; Duan, Wenrui; Gatcliffe, Troy; Diaz, Zuanel; Schroeder, Eric; Lambrou, Nicholas; Eiseler, Nicole; Morrissey, Thomas; Villalona-Calero, Miguel

authors

publication date

  • August 1, 2021

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • Science & Technology

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • S66

end page

  • S67

volume

  • 162